Accelerated assessment procedures support the conduct of drug trials in Estonia and Europe
The State Agency of Medicines has established a national accelerated assessment procedure and is als...
Publisher
Estonia
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The State Agency of Medicines has established a national accelerated assessment procedure and is als...
Source route
Continue on ravimiamet.ee
Leave the platform to read the original full article on the publisher site.
Source: SAM Estonia
Scope: Regulatory
Related coverage
More related coverage
Guidance: Archiving and retention of clinical trial records
Information on clinical trial record retention and archiving requirements including requirements for...
Clinical trials for medicines: good manufacturing practice and radiopharmaceutical investigational medicinal products
Guidance on good manufacturing practice and the use of radiopharmaceutical investigational medicinal...
Transparency data: MHRA Performance Data
Performance data for MHRA key performance indicators (KPIs) and information on the expected timeline...
OMNIPAQUE 300 mg, OMNIPAQUE 350 mg Iodo /ml SOLUCION INYECTABLE y VISIPAQUE 320 mg /ml SOLUCION INYECTABLE
Formato pdf Fecha de publicación: 26 de marzo de 2026 Nº alerta: R_16/2026 Fecha: 25 de marzo de 202...